Mana.bio: Funding, Investors & Team (Oct 2026)
Mana.bio is a startup that utilizes artificial intelligence for delivering medications, specifically targeting gene therapy such as DNA and RNA-based treatments, as well as vaccines.
Mana.bio has raised $24.5M across 3 funding rounds on record, the most recent a Seed announced in Sep 2025.
Mana.bio Company Profile and Key Stats
Latest funding round on record: Sep 2025.
Mana.bio Funding Rounds
1 of 3 rounds was announced without a disclosed amount and is excluded from the total.
Mana.bio raised $5.0M in a Seed announced in Oct 2022.
1 years later, a Seed of $19.5M was announced in Oct 2023.
1.9 years later, a Seed was announced in Sep 2025 with no disclosed amount.
Mana.bio Founders and Leadership Team
Contact details for the Mana.bio team: 2 of 2 have an email address on file.
Start 14-day free trial →Mana.bio Funding Compared to Other Biotechnology Startups
Funded Startups Like Mana.bio in Biotechnology and San Francisco
Companies Similar to Mana.bio
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Mana.bio Funding FAQs
What does Mana.bio do?
Mana.bio is a startup that utilizes artificial intelligence for delivering medications, specifically targeting gene therapy such as DNA and RNA-based treatments, as well as vaccines.
How much funding has Mana.bio raised?
Mana.bio has raised $24.5M across 3 rounds on record.
When did Mana.bio last raise funding?
Mana.bio's most recent funding round on record was announced in Sep 2025. The amount was not disclosed.
Who founded Mana.bio?
FundedIQ lists Roy Nevo (Founder) at Mana.bio.
Who is the CEO of Mana.bio?
Yogev Debbi is listed as CEO at Mana.bio.
Where is Mana.bio headquartered?
Mana.bio is based in San Francisco, California, United States.
How many employees does Mana.bio have?
Mana.bio is in the 11-50 employee band.
About FundedIQ's Mana.bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Mana.bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.